• Proposed non-underwritten institutional placement to raise ~A$20 million
• Concurrent non-underwritten share purchase plan for eligible shareholders
• Presentation covers company overview, strategy, and financial information

Lumos Diagnostics Holdings Ltd has released an investor presentation providing information on the company's operations, strategy, and financial performance. The key points of the presentation include a proposed non-underwritten institutional placement to raise approximately A$20 million, as well as a concurrent non-underwritten share purchase plan for eligible shareholders. The presentation covers the company's business model, product portfolio, market opportunities, and financial information. It also includes disclaimers and important information regarding forward-looking statements, financial data, and the offer structure. The presentation is intended to provide investors with an overview of Lumos Diagnostics' current position and future plans.